STONERIDGE INVESTMENT PARTNERS LLC - ONCOGENEX PHARMACEUTICALS IN ownership

ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 76 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q1 2014. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
STONERIDGE INVESTMENT PARTNERS LLC ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2015$73,000
-53.2%
60,477
-13.8%
0.01%
-54.5%
Q3 2015$156,000
-5.5%
70,152
-0.8%
0.02%
+10.0%
Q2 2015$165,000
+48.6%
70,702
+37.3%
0.02%
+53.8%
Q1 2015$111,000
-1.8%
51,512
+4.1%
0.01%
-13.3%
Q4 2014$113,000
+6.6%
49,471
+24.6%
0.02%
-6.2%
Q3 2014$106,000
+49.3%
39,710
+107.2%
0.02%
+45.5%
Q2 2014$71,000
-69.4%
19,163
-2.9%
0.01%
-75.6%
Q1 2014$232,000
+40.6%
19,7380.0%0.04%
+40.6%
Q4 2013$165,000
-10.3%
19,738
-0.5%
0.03%
-20.0%
Q3 2013$184,000
+17.2%
19,838
+23.7%
0.04%
+8.1%
Q2 2013$157,00016,0380.04%
Other shareholders
ONCOGENEX PHARMACEUTICALS IN shareholders Q1 2014
NameSharesValueWeighting ↓
Steamboat Capital Partners, LLC 817,521$414,0000.37%
Abingworth LLP 396,104$195,0000.19%
BOOTHBAY FUND MANAGEMENT, LLC 60,638$31,0000.01%
EAGLE GLOBAL ADVISORS LLC 128,520$65,0000.00%
PANAGORA ASSET MANAGEMENT INC 949,438$481,0000.00%
Renaissance Technologies 908,100$460,0000.00%
PRICE T ROWE ASSOCIATES INC /MD/ 46,100$23,0000.00%
DEUTSCHE BANK AG\ 5$00.00%
CITIGROUP INC 10,376$5,0000.00%
GOLDMAN SACHS GROUP INC 20,037$10,0000.00%
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders